MyFastRx logo

MyFastRx Review

7.0
★★★★☆3.5/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7/10

Best for: Cash-pay patients who want flat-rate compounded GLP-1s month to month, with an option to prepay for less.

Price is where MyFastRx scores best in our breakdown.

Code50%Off 1st mo

MyFastRx coupon & promo code

Semaglutide$69/mo was$139

Promo code: MY70
First month, then $139/mo · New patients only

Semaglutide

$69/mo · first month

then $139/mo ongoing

Tirzepatide

$129/mo · first month

then $199/mo ongoing

Same price at every dose

Price checked on MyFastRx’s site,

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not stated

Coaching

Not stated

Get the $69/mo deal →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

MyFastRx is a cash-pay telehealth platform selling compounded semaglutide and tirzepatide at one price for every dose, with the provider review and express shipping included. Semaglutide is $139/mo ($69 for the first month) and tirzepatide is $199/mo ($129 first month). Prepaid 3-, 6- and 12-month plans cut that to as low as $79/mo and $124/mo. It takes no insurance and does not auto-refill orders.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideLegitScript VerifiedHIPAA CompliantSame Price at Every DoseMulti-Month Plan DiscountsFree Express Shipping

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to MyFastRx

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
MyFastRx logo
3.5 / 5
Our editorial rating
Visit MyFastRx →

from $139/mo (after intro offer) · no insurance needed

MyFastRx at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$139/mo (after intro offer) ($69 first month)
Pricing model
Flat: dose increases don't raise the monthly price
What's included
Medication · Consult · Shipping
Availability
49 states
FDA status
No FDA warning letter on record

How we scored MyFastRx

Each dimension is scored algorithmically from MyFastRx’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

7.7/10

At $139/mo (after intro offer), MyFastRx runs about 22% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $69. Pricing is flat across doses, so there is no escalation markup as you titrate up.

Effectiveness25%

7.3/10

MyFastRx offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

6.6/10

Online intake and platform experience (consult included in the price); 8 platform features disclosed.

Trust & Safety15%

6.5/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

7.5/10

MyFastRx is available in 49 states: all but Louisiana.

Support10%

5.1/10

MyFastRx provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this MyFastRx review

Last checked October 2026
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed availability in 49 states
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$139–$199/mo across 2 dose/plan tiers (checked October 2026)
State pharmacy licensing & LegitScript status
LegitScript Verified
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with MyFastRx

We walked MyFastRx’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Pick semaglutide or tirzepatide on MyFastRx's website; each page shows the first-month price, the regular monthly price and 3-, 6- and 12-month plan prices.
  2. 2Click 'Start My Online Visit' to open the onboarding form ('Step 1 of 4').
  3. 3The first screen asks for your state together with your name, email, phone number and text-message consent.
Price shown before you start
  • Prices are clear before intake: $139/mo semaglutide and $199/mo tirzepatide at every dose, with $70 off the first month using code MY70.
  • Multi-month plans are billed upfront ($297 to $948 for semaglutide, $498 to $1,488 for tirzepatide).
  • The FAQ says you're charged when you place the order, and refunded if a provider doesn't approve you.
  • Monthly orders don't auto-refill; you reorder through the member portal each time.
  • The FAQ says some states require a video visit or phone consultation, and you may be asked for a photo ID and selfie.
  • The state list on the sign-up form leaves out Louisiana.
  • The refund policy spells out how a canceled prepaid plan is refunded, with a worked example.

MyFastRx customer support

GLP-1 medications MyFastRx offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

Month-to-month, same price at every doseCompounded
$139$69/mo
Save 50% right now
semaglutide

$69 first month with code MY70 (new customers), then $139/mo; no auto-refills. Longer plans: 3-mo $99/mo ($297), 6-mo $89/mo ($534), 12-mo $79/mo ($948), billed upfront.

Month-to-month, same price at every doseCompounded
$199$129/mo
Save 35% right now
tirzepatide

$129 first month with code MY70 (new customers), then $199/mo; no auto-refills. Longer plans: 3-mo $166/mo ($498), 6-mo $149/mo ($894), 12-mo $124/mo ($1,488), billed upfront.

Ready to get started?

Plans and promotions change often, so check MyFastRx's current pricing and active discounts before you decide.

See MyFastRx pricing →

What we like

  • Low month-to-month pricing: $139/mo semaglutide and $199/mo tirzepatide, with a $70-off first month
  • Same price at every dose, so your bill doesn't rise as you titrate up
  • Provider review and free express shipping are included, with no membership fee
  • No automatic refills or recurring charges on monthly orders
  • Prepaid 3-, 6- and 12-month plans drop the rate to as low as $79/mo (semaglutide)
  • Published multi-month refund formula with no extra cancellation fee
  • LegitScript certified

Watch-outs

  • Pharmacy partner not named, only 'licensed U.S. pharmacies'
  • No named medical director
  • Cash-pay only; no insurance
  • The lowest rates require paying 3 to 12 months upfront
  • Canceling a prepaid plan reprices what you've received at the shorter-plan rate
  • Not available in Louisiana
  • Some states require a video visit or phone consult before approval
  • You're charged when you order, before a provider reviews your intake (refunded if not approved)

MyFastRx: low month-to-month compounded GLP-1, cheaper still if you prepay

MyFastRx is a cash-pay telehealth platform built around one idea: get you approved fast and keep the price simple. Compounded semaglutide runs $139 a month (after intro offer) on a plain monthly order, and new customers pay $69 for the first month with code MY70. That standard rate already sits below the category median of $179. Prepay a longer plan and it drops further. Price is the easy part here; the harder call is trusting a provider that doesn't name its pharmacy or its medical director.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.

How the pricing works

Monthly orders are the default, and they don't auto-refill. Compounded semaglutide is $139 a month (after intro offer), and compounded tirzepatide is $199 a month at any dose. The MY70 code cuts the first month to $69 for semaglutide or $129 for tirzepatide. From there, prepaid 3-, 6- and 12-month plans step the rate down: semaglutide goes from $99 a month on the 3-month plan to $79 on the 12-month plan, and tirzepatide bottoms out at $124.

The longer plans are billed upfront. A full year of semaglutide is a single $948 charge to a provider whose pharmacy partner and medical director aren't named. If you cancel a prepaid plan, what you've already received is repriced at the shorter-plan rate, and the rest is refunded with no extra fee. That's a fair, published formula, but it means the deepest discount only holds if you finish the plan.

One price at every dose

Every dose costs the same. Many compounded-GLP-1 sellers raise your monthly bill as you titrate up to higher strengths, which punishes you right as the medication starts working. MyFastRx prices all doses identically, so your rate doesn't move from a starter dose to a full maintenance dose. Over a year of dose escalation, that can save a meaningful sum compared with a provider that charges by strength.

What the price includes

  • Compounded semaglutide or compounded tirzepatide, injectable
  • Provider review included, with no separate visit fee or membership
  • Free express shipping
  • The same price at every dose as you titrate up
  • No auto-refills on monthly orders, plus optional 3-, 6- or 12-month prepaid plans

The medications and how they're dispensed

MyFastRx deals only in compounded versions of semaglutide and tirzepatide. They contain the same active ingredients as the brand-name injectables, prepared by a compounding pharmacy rather than the original manufacturer. There's no brand-name Wegovy, Zepbound, or Ozempic option here, and no oral pill. For readers who put brand-name access first, Elevate Health offers Zepbound next to its compounded plans and takes payment plans, but it doesn't name its pharmacy either. The provider review and shipping are in the listed price, and you're charged when you order, then refunded if a provider decides treatment isn't appropriate.

What MyFastRx will not tell you is which pharmacy makes your medication. The site references 'licensed U.S. pharmacies' but names no specific 503A or 503B partner. For a compounded product, where the pharmacy is the quality control, that's a meaningful gap, because you're trusting the platform's vetting without being able to check the source yourself.

Trust and safety: a mixed picture

On the positive side, MyFastRx displays a LegitScript seal tied to its own domain, a third-party credential in this market. It says it's HIPAA-compliant, and it operates as MyFastRx Health LLC with a published Boca Raton, Florida mailing address, phone line, and support email. We have no FDA warning letter on file for it. The onboarding form lists 49 states and leaves out Louisiana, and some states need a video or phone visit first.

The disclosure gaps hold it back: no medical director is named, the pharmacy partner stays anonymous, and disputes go to binding arbitration in San Diego. If you live in Texas and a named physician matters more to you, MedLeanRx lists its supervising doctor and offers semaglutide tablets and a brand-name pathway, but its pharmacy isn't named. Our scoring methodology counts undisclosed oversight against a provider, and MyFastRx loses points for it. The prices are published in full, but the clinicians and pharmacy behind the brand stay out of view.

Who should choose it, and who should skip it

Choose MyFastRx if you're a cash-pay patient who wants a low monthly price without a subscription, and you value flat per-dose pricing. It's especially good for someone who expects to titrate to a higher maintenance dose. If you're already sure you're in for the long haul, the prepaid plans cut the rate further.

Skip it if you need insurance billing, since MyFastRx is self-pay only, or if you live in Louisiana. And skip it if undisclosed oversight is a dealbreaker: a named pharmacy and a published medical director are things some competitors offer, and if that matters, you can find it elsewhere.

Bottom line

MyFastRx earns its place as a value option for cash-pay GLP-1 patients. Semaglutide at $139 a month (after intro offer) with no auto-refill is competitive, and flat dosing is a patient-friendly touch too few providers offer. The prepaid plans go lower, with a clear refund formula if you stop early. The trade-off is transparency, since the pharmacy and medical leadership stay private. If you can live with that, it's a smart deal; if not, a more transparent provider may cost a few dollars more.

The Bottom Line

Price is where MyFastRx scores best in our breakdown.

Score: 7/10Best for: Cash-pay patients who want flat-rate compounded GLP-1s month to month, with an option to prepay for less.From: $139/mo (after intro offer)

Ready to start with MyFastRx?

From $139/mo (after intro offer). See current pricing and start your free consultation.

MyFastRx might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
  • If the lowest possible monthly price is your top priority, consider YourEra (from $89/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.

Head-to-head

Compare MyFastRx vs…

MyFastRx scores7.0/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

MyFastRx is a cash-pay telehealth platform offering compounded semaglutide and tirzepatide at one price for every dose. You complete an online intake, a licensed U.S. provider reviews it (typically within 24 hours), and if treatment is appropriate your medication ships free to your door.
MyFastRx offers compounded semaglutide and tirzepatide, not the brand-name products. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
Compounded semaglutide is $139/month and tirzepatide is $199/month, the same at every dose, with provider review and shipping included. New customers get $70 off the first month with code MY70 ($69 and $129). Prepaid plans lower the rate: semaglutide $99, $89 or $79/month on 3-, 6- or 12-month plans, and tirzepatide $166, $149 or $124/month.
MyFastRx says it serves patients across the United States but that availability varies by state. Its sign-up form lists 49 states, including Alaska but not Louisiana. Some states require a video visit or phone consultation before approval.
No. MyFastRx is cash-pay only and does not accept insurance. Some HSA or FSA cards may work, depending on your card issuer.
Monthly orders have no subscription and are not refilled automatically; you reorder each time. Prepaid multi-month plans are billed upfront and shipped in three-month supplies. If you cancel a prepaid plan, you get back what you paid minus the shorter-plan price of medication already sent, and there is no extra cancellation fee.
Yes, MyFastRx offers code MY70 (Code MY70 (new customers): $69 first month compounded semaglutide (then $139/mo) or $129 tirzepatide (then $199/mo)). Apply it on MyFastRx's own checkout via the link on this page, and ignore third-party sites listing other "MyFastRx codes", which are typically fake.
MyFastRx is an operating telehealth provider, and we found no FDA warning letter on file for it. On its public pages, it shows LegitScript certification. We could not confirm the name of the pharmacy that fills its prescriptions from its public pages. We last checked its prices and policies on its own site in October 2026. We scored it 7.0/10 from published information, which is not a clinical endorsement. Talk to a licensed clinician before starting any medication.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for MyFastRx. The concerns our review flags: Pharmacy partner not named, only 'licensed U.S. pharmacies'; No named medical director; Cash-pay only; no insurance; The lowest rates require paying 3 to 12 months upfront. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this MyFastRx review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See MyFastRx's current pricing

Plans from $139/mo (after intro offer). Start your free consultation to check eligibility and today's price.